It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Evolutionary arms races are broadly prevalent among organisms including bacteria, which have evolved defensive strategies against various attackers. A common microbial aggression mechanism is the type VI secretion system (T6SS), a contact-dependent bacterial weapon used to deliver toxic effector proteins into adjacent target cells. Sibling cells constitutively express immunity proteins that neutralize effectors. However, less is known about factors that protect non-sibling bacteria from T6SS attacks independently of cognate immunity proteins. In this study, we observe that human Escherichia coli commensal strains sensitive to T6SS attacks from Vibrio cholerae are protected when co-cultured with glucose. We confirm that glucose does not impair V. cholerae T6SS activity. Instead, we find that cells lacking the cAMP receptor protein (CRP), which regulates expression of hundreds of genes in response to glucose, survive significantly better against V. cholerae T6SS attacks even in the absence of glucose. Finally, we show that the glucose-mediated T6SS protection varies with different targets and killers. Our findings highlight the first example of an extracellular small molecule modulating a genetically controlled response for protection against T6SS attacks. This discovery may have major implications for microbial interactions during pathogen-host colonization and survival of bacteria in environmental communities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Georgia Institute of Technology, School of Biological Sciences, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943); Georgia Institute of Technology, Parker H. Petit Institute for Bioengineering & Bioscience, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943); Georgia Institute of Technology, Center for Microbial Dynamics and Infection, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
2 Georgia Institute of Technology, Center for Microbial Dynamics and Infection, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943); Georgia Institute of Technology, School of Physics, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)